Study: Optimizing Cell Viability During CHO Cell Freezing

Alexander Fuchs | Single Use Support

Alexander Fuchs

February 16, 2024

Table of contents

Show

Improving Cryogenic Freezing of a Mammalian Cell Line

A study was conducted aiming to optimize the cryogenic freezing process of CHO-K1 cell line using an innovative controlled rate liquid nitrogen freezer (RoSS.LN2F). The mammalian cells were filled into 250mL single-use bags and protected by RoSS.KSET.

The study included three different freeze runs at different cooling rates in the controlled rate RoSS.LN2F, as well as an additional uncontrolled freeze run in a static freezer for comparison purposes.  

To comprehensively assess the impact of varying freezing rates on post-thaw cell recovery, the study incorporated three viability assays: Trypan blue, LIVE/DEAD and Fluorescence.

Study Results: Optimal Freezing Protocol for Cell-based Therapies

Intra-experimental variations between the different freezing runs were minor. The study suggests that a freezing rate of −1°C/min is optimal for mammalian cell lines.

However, the study also emphasized on cell survival rate for other freezing rates, as the optimal cooling rate is not limited to -1°C/min. The results show that the range of optimal cooling rates can be expanded to a certain level.

The study also highlights the importance of controlling the freezing process. What are the consequences of freezing in an uncontrolled environment, such as a static freezer, compared to a recipe-driven, standardized, and scalable controlled freezing protocol?  

Please download the Study Summary for further information.

Study: Increased CHO Cell Viability with Controlled Liquid Nitrogen Freezer

The study was conducted aiming to optimize the cryogenic freezing process of the mammalian CHO-K1 cell line with an innovative controlled rate liquid nitrogen freezer (RoSS.LN2F). The study incorporated three viability assays to comprehensively assess the impact of varying freezing rates on post-thaw cell recovery | Trypan blue | LIVE/DEAD | Fluorescence.

More Information

RoSS.KSET top view

ROSS.KSET | Protecting small single-use bags

RoSS.KSET offers the protection for drug substances with volumes less than 250 mL. The shell of our CGT bag protection system is robust, closed, safe and sterile – most suitable for cell and gene therapies or clinical studies.

For larger volumes, RoSS can protect one or multiple single-use bags in one shell.

Cryogenic Freezer RoSS LN2F

RoSS.LN2F | Cryogenic Freezer

RoSS.LN2F is a powerful cryogenic controlled rate freezer for temperatures down to -170°C/-274°F. An enclosed LN2 system and our innovative direct injection system ensure no direct exposure and no mechanical compressors are needed. This ensures a safe, low-maintenance and energy-saving handling.

How to measure and improve cell viability?

How to measure and improve cell viability?

Cell viability is a fundamental parameter in cell-based biopharma processing and cell banking. Therefore, it is essential not only to measure cell viability, but also to take measures for its improvement. Learn more in this article.

Cell viability: 7 facts to be aware of

Cell viability: 7 facts to be aware of

In research, medicine and biotechnology, cell viability is an elementary parameter and Critical Quality Attribute (CQA). In this article, we will present you 7 facts regarding the term, related concepts, improvement possibilities and more.

Alexander Fuchs | Single Use Support

Alexander Fuchs

Head of Product Line Management

Alexander is Head of Product Line Management. He owns a wide range of experience and knowledge in various and different industries such as jewellery, manufacturing industry and biopharma, and multiple areas of activities due to his highly technical education and intensive insights. 

Passionate for Automation, Engineering and Process Management Alexander contributes to the innovative focus of advancing cold chain management within the biopharmaceutical industry. 

More from Alexander Fuchs

Vaccines

Freeze thaw processes in biosimilar production

Freezing and thawing are essential steps in the cold chain management of biosimilars. With several methods eligible, we have chosen some prominent ones, explaining their advantages, limitations, and our preferred choices.

Alexander Fuchs | Single Use Support

Alexander Fuchs

May 8, 2024

Vaccines

Safe storage of biologics: Requirements & solutions

Once biologics are produced, they need to be stored for shorter or longer periods of time, with dedicated storage requirements to be met. Here, we will uncover these requirements, along with solutions to fulfill them.

Alexander Fuchs | Single Use Support

Alexander Fuchs

May 8, 2024

Read more about Cell & Gene Therapy

Cell & Gene Therapy

DMSO: Freezing Cells

Freezing cells is a process that requires more than simply placing them in a freezer with dimethyl sulfoxide (DMSO). It is a precise and meticulous process, where precision and expertise are essential. The goal is to achieve high cell viability and therefore high yield for cell-based therapies or cell banking.

Khalil Essani - Single Use Support

Khalil Essani

October 11, 2024

Cell & Gene Therapy

Regulations for Cryoprotectants in ATMP Cryopreservation

Adequate quality control samples retained before cell therapy treatment are a crucial component of effective regulation and need to represent the conditions and history in the cryobag. A deep dive into GMP Annex 1 on ATMP Cryopreservation.

Khalil Essani - Single Use Support

Khalil Essani

February 7, 2024

Cell & Gene Therapy

Stressing Cells: The Role of Cryoprotectants in ATMP Cryopreservation

The objective of an optimal cryopreservation strategy is to deactivate (put on hold) degenerative cellular pathways and preserve proliferative potential by reducing the temperature below –130°C. To reduce the effects of ice crystal and osmotic injuries, cryopreservation protocols usually incorporate cryoprotective agents (CPAs).

Khalil Essani - Single Use Support

Khalil Essani

February 8, 2024

Cell & Gene Therapy

Optimizing pDNA production using advanced single-use technologies

Considering the widespread need for efficient pDNA production, the industry is seeking to improve the current manufacturing process. In this article, we will discover how single-use technologies can contribute to pDNA manufacturing optimizations.

Khalil Essani - Single Use Support

Khalil Essani

November 10, 2023